News Conference News EuroPCR 2023 QFR More Consistent Than FFR in Nonculprit Lesions After STEMI Caitlin E. Cox May 24, 2023
News Conference News EuroPCR 2023 Many ACS Patients With Occlusions Are Falling Through the Cracks Todd Neale May 19, 2023
News Daily News To Boost Access and Outcomes With New PCI Centers, Location Matters L.A. McKeown May 08, 2023
News Daily News Hospitals That Set STEMI Standards Can Better Serve Black Patients Caitlin E. Cox April 25, 2023
News Daily News A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4 Shelley Wood April 14, 2023
News Daily News Around the World, Finances Impact Acute MI Outcomes in Older Adults Caitlin E. Cox April 04, 2023
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Daily News SCAI Updates Position on Doing PCI Without Surgical Backup Michael O'Riordan February 20, 2023
News Conference News STS 2023 Earlier, More-Active Surgeon Involvement Needed in PE Care: AHA Yael L. Maxwell January 27, 2023
News Daily News ‘Total Ischemic Time’ Key to Cutting NSTEMI Deaths With Invasive Strategy Yael L. Maxwell January 11, 2023
News Daily News Shifting Acute MI Outcomes by Medicare Type: A Window Into Insurer’s Influence L.A. McKeown December 09, 2022
News Conference News PCR London Valves 2022 TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story Shelley Wood November 30, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD Yael L. Maxwell November 21, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022